A 2025 clinical summary reported a 50% reduction in side effects associated with microdosing strategies, a significant indicator of tolerability in routine care, according to Doctronic
Building on the Tier 1 foundations from Episode 22 (creatine, whey protein, and caffeine), Layne breaks down the science, mechanisms, optimal dosing, timing, safety profiles, and real-world takeaways for these promising options
Therefore, the GH-stimulating effect of GHRP-2 can indeed be a valuable asset for fat metabolism and body recomposition
SKIN-NOURISHING INGREDIENTS: Niacinamide and Panthenol in our peptides serum help support smoother-looking skin and refine pores
Should GLP-1 therapy replace traditional AF treatments
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical